knowledge -WSS

knowledge

author：explore 2025-08-12 09:08:54 - browse：687

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Pharma showers House GOP doctor with campaign cash

WSS

Physicians aren't 'burning out.' They're suffering from moral injury

ProMED sees offers of support, but its future remains unclear

Baltimore teen accused of firing into crowd during block party mass shooting

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Liz Cheney makes 1st public comment since Trump's election interference indictments

Trump cancels press conference intended to dispute Georgia election interference charges

leisure time

knowledge

explore

Tori Bowie and the unacceptable rates of Black maternal death

Trump's false claims about Georgia's 2020 election long debunked

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ProMED sees offers of support, but its future remains unclear

Hepatitis C has a cure — but many Americans still lack access to it

Physicians aren't 'burning out.' They're suffering from moral injury

At least 13 dead in Texas as scorching temps continue

Hilary expected to bring catastrophic, life

Wildfire smoke exposes gaps in outdoor worker protections

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

focus

Study links childhood stress with decline in older age

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

CDC recommends RSV monoclonal antibody for infants

FDA approves Sage Therapeutics’ rapid

Late stage cancers on the rise after pandemic delayed screenings

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

hotspot

Wikipedia

knowledge

hotspot